genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Forest Laboratories
Industry News
Forest Labs Acquiring Aptalis for $2.9B
Infectious Diseases
Forest Coughs Up $25M for Nabriva’s Phase II Antibacterial, Right to Take Over Company
News
Icahn Throws Down the Gauntlet in Second Try for Forest Labs Board Seats
News
Pierre Fabre, Forest Report Positive Data from Third Phase III Depression Trial
News
Gedeon Richter, Forest Report Positive Phase III Data in Schizophrenia
News
Gedeon Richter, Forest Drug Cariprazine Succeeds in Third Phase III Bipoar Disorder Study
News
Biopharma M&As in 2012
News
Forest and Gedeon Richter Report Positive Phase III Data for Antipsychotic
News
Forest and Pierre Fabre Report Positive Data from Second Phase III Antidepressant Trial
News
Almirall and Forest Project Mid-2011 Aclidinium Filing as Third Phase III COPD Trial Triumphs
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
